Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Monday, June 17, 2024 | Back issues
Courthouse News Service Courthouse News Service

Biotech IPO

SAN MATEO, Calif. - Pacific Biosciences overstated its prospects to raise $230 million through its initial public offering, at $16 a share, and the stock price sank to $4.25 after this and the company's "cash burn" were revealed, shareholders say in a class action in Superior Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...